Spotlight on Pegfilgrastim in Chemotherapy-Induced Neutropenia

被引：0
|
作者：
James E. Frampton
Gillian M. Keating
机构：
[1] Adis International Inc.,
来源：
BioDrugs | 2005年 / 19卷
关键词：
Breast Cancer; Acute Myeloid Leukemia; Febrile Neutropenia; Filgrastim; Chemotherapy Cycle;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pegfilgrastim (Neulasta®), the sustained-duration form of filgrastim (recombinant human granulocyte colony-stimulating factor [G-CSF]), is created by the addition of a polyethylene glycol (PEG) moiety to filgrastim. Its approved indication in the US is to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy.
引用
收藏
页码：405 / 407
页数：2
相关论文
共 50 条
  • [1] Spotlight on pegfilgrastim in chemotherapy-induced neutropenial
    Frampton, JE
    Keating, GM
    BIODRUGS, 2005, 19 (06) : 405 - 407
  • [2] Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia
    Rofail, Pierre
    Tadros, Mariam
    Ywakim, Riham
    Tadrous, Mina
    Krug, Allison
    Cosler, Leon E.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (06) : 699 - 709
  • [3] Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia
    Waladkhani, AR
    EUROPEAN JOURNAL OF CANCER CARE, 2004, 13 (04) : 371 - 379
  • [4] Pegfilgrastim in the primary prophylaxis of chemotherapy-induced severe neutropenia
    Olvera Alberto, Serrano
    Fernando, Alban
    Alberto, Villalobos
    Cwilich Raquel, Gerson
    GACETA MEXICANA DE ONCOLOGIA, 2010, 9 (01): : 3 - 10
  • [5] Introduction: Pegfilgrastim, a new era in the management of chemotherapy-induced neutropenia
    Petros, WP
    PHARMACOTHERAPY, 2003, 23 (08): : 1S - 2S
  • [6] Pegfilgrastim -: Rational drug design for the management of chemotherapy-induced neutropenia
    Lüftner, D
    Possinger, K
    ONKOLOGIE, 2005, 28 (11): : 595 - 602
  • [7] Prevention of Chemotherapy-Induced Neutropenia with Pegfilgrastim: Pharmacokinetics and Patient Outcomes
    Yang, Bing-Bing
    Savin, Michael A.
    Green, Michael
    CHEMOTHERAPY, 2012, 58 (05) : 387 - 398
  • [8] RGB-02 (biosimilar pegfilgrastim) in the treatment of chemotherapy-induced neutropenia
    Santha, Dora
    Illes, Andras
    Aradi, Ildiko
    Horvat-Karajz, Karoly
    Kahan, Zsuzsanna
    FUTURE ONCOLOGY, 2019, 15 (18) : 2083 - 2092
  • [9] Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors
    Lambertini, Matteo
    Ferreira, Arlindo R.
    Del Mastro, Lucia
    Danesi, Romano
    Pronzato, Paolo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1799 - 1817
  • [10] Once-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropenia
    Crawford, J
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 24 - 30
12345